TANG CAPITAL MANAGEMENT LLC
Q1 2026 13F Holdings
- Locationsan diego, CA
- Num holdings
51
- Value ($000)
$1,968,963
- Date Filed 05/15/2026
- Form type13F-HR
- CIK 0001232621
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | $181.24M | 9 % | 12,229,500 | ||
CELCUITY INC | COM | 15102K100 | $119.85M | 6 % | 1,050,000 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | $114.18M | 6 % | 1,236,027 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | $113.58M | 6 % | 3,785,991 | ||
STATE STR SPDR S&P 500 ETF T | TR UNIT | 78462F103 | $109.26M | 6 % | 168,000 | ||
KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | $108.81M | 6 % | 2,259,889 | ||
CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | $103.36M | 5 % | 3,399,900 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | $102.2M | 5 % | 1,500,000 | ||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | $95.44M | 5 % | 1,892,200 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | $92.07M | 5 % | 4,573,530 |
Rows Per Page
10
- 10
- 50
- 100